CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 92 enrolled
Drug / intervention
Egg Oral Immunotherapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01846208
NCT01846208Phase 2Completed
CompareCT.gov

Oral Desensitization to Egg With Subsequent Induction of Sustained Unresponsiveness for Egg-Allergic Children Using Baked Egg or Egg Oral Immunotherapy (OIT)

Hugh A Sampson, MD·interventional·Posted May 3, 2013·Updated Jul 26, 2019

In Brief

A Phase 2 clinical trial evaluating Egg Oral Immunotherapy and Baked Egg for Food Allergy. Completed, enrolled 92 participants across 5 sites.

Detailed Summary

The purpose of this study is to compare Baked Egg vs. Egg Oral Immunotherapy for inducing sustained unresponsiveness to egg exposure in children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFood Allergy
CountriesUnited States
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID), Consortium of Food Allergy Research

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 3, 2013
Enrollment StartJul 1, 2013
Primary CompletionSep 28, 2017
Study CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 13.2 years ago

Interventions

Egg Oral Immunotherapydrug

Commercially available egg white solid dispensed by the central manufacturer. Study product will be dispensed in vials for low doses, capsules for mid-range doses, and bulk powder with dosing scoops for the higher doses.

Baked Eggdrug

Predetermined food substances with known amounts of Baked Egg (egg protein) with standardized dosing/consumption instructions.